MELAS: Clinical features, biochemistry, and molecular geneticsEmma Ciafaloni, S. DiMauro, Enzo Ricci et al.|Annals of Neurology|1992Cited by 508
Mitochondrial <scp>DNA</scp> damage and reactive oxygen species in neurodegenerative diseaseNadee Nissanka, Carlos T. Moraes|FEBS Letters|2017Cited by 426
Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNACarlos T. Moraes, S. DiMauro, Eric A. Schon et al.|Neuromuscular Disorders|1993Cited by 238
The mitochondrial DNA polymerase gamma degrades linear DNA fragments precluding the formation of deletionsNadee Nissanka, Carlos T. Moraes|Nature Communications|2018Cited by 127
Striatal Dysfunctions Associated with Mitochondrial DNA Damage in Dopaminergic Neurons in a Mouse Model of Parkinson's DiseaseAlicia M. Pickrell, Carlos T. Moraes|Journal of Neuroscience|2011Cited by 120